Medivizor

Title of notification

Here comes the notification
X
 
 

colorectal cancer

Research

Treatment

Source: International Journal of Colorectal Disease

icon
icon
  • Published: Apr 16, 2020
  • Added to your feed: Jun 13, 2020
  • Added by Medivizor: May 09, 2020
  • Updated by Medivizor: May 09, 2020
  • How common are late side effects after radiation treatment for rectal cancer?

    In a nutshell

    This study investigated the frequency of late gastrointestinal (GI) side effects after radiation therapy (RT) for rectal cancer. Researchers suggested that after the improvement of RT methods these side effects are less frequent and less severe.

    Some background

    Colorectal cancer is one of the most frequently diagnosed cancers in the US. Of these, 29% are rectal cancers. The standard treatment for rectal cancer is surgery followed by RT and chemotherapy. RT consists of the use of high-energy rays to damage cancer cells and stop them from growing. It is associated with side effects due to affecting not only cancer cells but healthy cells too.

    Prior studies showed the side effects rates at early stages, which usually appear between weeks 1 and 3 after RT. However, too little is known about the late side effects that may appear after RT.

    Methods & findings

    This study reviewed 9 other studies about RT for rectal cancer. Information about 2115 patients was analyzed.

    The overall occurrence of late severe side effects was 19%. The most common side effects were diarrhea (35%), fecal incontinence (involuntary leakage of stool; 22%), gas incontinence (71%), rectal bleeding (9%), rectal pain (13%) and obstruction (7.4%).

    Treatment before surgery and more advanced RT techniques resulted in lower rates of late side effects. 

    The bottom line

    This study concluded that improved RT techniques decrease the rate of late side effects after rectal cancer radiation treatment.

    The fine print

    This study was based on information from medical records. Data may have been missing. Further studies are needed.

    Disclaimer:
    This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided by Medivizor solely at your own risk. Medivizor makes no warranties or representations as to the accuracy of information provided herein. If you have any concerns about your health, please consult a physician.

    Discussion about this item

    Follow this discussion

    Notes:



     

    Was this helpful?

    Ask a question